Lv3
370 积分 2025-03-12 加入
ZUMA-19: A Phase 1/2 Study of Axicabtagene Ciloleucel Plus Lenzilumab in Patients With Relapsed or Refractory Large B-Cell Lymphoma
2个月前
已关闭
Overcoming solid-tumor barriers: armored CAR-T cell therapy
2个月前
已完结
The Role of Extracellular Spacer Regions in the Optimal Design of Chimeric Immune Receptors
3个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
4个月前
已完结
Antigen-specific T cells and autoimmunity
6个月前
已完结
Antigen-specific immunotherapies for autoimmune disease
7个月前
已完结
Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy
8个月前
已完结
Big pharma buys into exosomes for drug delivery
9个月前
已完结
Osteoarthritis
9个月前
已完结
皖公网安备34019202002308
